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Abstract
Background: Exposure to dioxins results in a broad range of pathophysiological disorders in
human fetuses. In order to evaluate the effects of dioxins on the feto-placental tissues, we analyzed
the gene expression in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treated primary cultures of
human amniotic epithelial cells.
Methods: Human amniotic epithelial cells were dispersed by trypsin from amniotic membranes
and cultured in DME/Ham's F12 medium supplemented with 10% FBS. Two weeks after plating,
cells were treated with 50 nM TCDD or DMSO (control), further incubated for 48 hrs, and the
gene expression was analyzed by DNA microarray technology and quantitative real-time PCR.
Results: Thirty eight TCDD-inducible genes, including cytochromeP4501A1 and
cytochromeP4501B1, were identified. One of the remarkable profiles of the gene expression was
the prominent up-regulation of interferon-inducible genes. The genes involved in the interferon
gene expression and interferon signaling pathways were also up-regulated. Furthermore, the
expression of genes related to collagen synthesis or degradation was enhanced by TCDD.
Conclusion: Using DNA microarray and quantitative real-time PCR analyses, we identified
TCDD-inducible genes, including interferon-inducible genes and genes related to collagen synthesis
or degradation, in human amniotic epithelial cells.
Background
Exposure to dioxins causes a diverse spectrum of toxicities
in humans and laboratory animals [1-4]. The fetus is one
of the most sensitive targets of dioxins and a broad range
of pathophysiological abnormalities, such as, disorders of
brain development, thyroxin resistance, hepatic damage,
hematopoietic disorders and lung dysfunction, are
observed in humans after perinatal exposure to dioxins
[1]. Dioxins are transferred to fetuses and infants through
placentas and milk from mothers [5]. Dioxins were
detected in all of the samples analyzed in a study per-
formed using human umbilical cord or cord serum in
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centa compared to that in breast milk, in a study per-
formed in Taiwan [7]. Not only the morphological and
functional disorders brought about by the altered gene
products but the comprehensive analyses of the change in
gene expression are required to evaluate the effects of fetal
exposure to endocrine disruptors [8]. However those stud-
ies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on
human feto-placentas are limited [6-13].
The amniotic membrane is of fetal origin but contains no
blood vessels [14]. The amniotic epithelial cells (AEC) on
the basement membrane which is the thickest among
basement membranes in human lay in the most interior
of the fetal membranes. From the histological character
mentioned above, it is relatively easier to obtain homoge-
nous cells for experiments without contamination of
hematocytes or cells of blood vessel origin [15]. Moreo-
ver, since fetal membranes are the tissues disposed of after
parturition, the ethical issues associated with use for
experiments are limited. Therefore, we analyzed gene
expression induced by TCDD, the most toxic congener
among the dioxins, in primary cultures of human AEC
using DNA microarray technology, a powerful tool in




2,3,7,8-TCDD was obtained from Cambridge Isotope
Laboratory (Andover, MA). Human oligonucleotide glass
array (Human Genome U133A Array) was from Affyme-
trix (Santa Clara, CA).
AEC culture and TCDD treatment
With the permission of The Internal Review Board for
Gunma University Hospital and the written informed
consent of the patients, we obtained fetal membrane sam-
ples from patients with single pregnancy without systemic
disease, signs of premature delivery or fetal complica-
tions, during elective cesarean sections at term. Three fetal
membranes from three women were used for independ-
ent primary cultures. AEC were prepared based on the
method described by Okita et al [15] with slight modifica-
tions, after an amniotic membrane was mechanically
peeled off from the chorion. Briefly, the membrane was
incubated in 170 ml of Krebs-Ringer solution containing
0.15 % trypsin, 1.26 g/l sodium bicarbonate, 25 mM
HEPES, 50 μg/ml streptomycin and 0.25 μg/ml amphoter-
icin B at 37C using a Spinner Flask. The liberated cells
were decanted at 30-min intervals and the incubation was
performed seven times with freshly made trypsin solu-
tion. Each fraction of dispersed cells were centrifuged,
resuspended in DME/Ham's F12 medium supplemented
with 15 mM HEPES, 10% FBS, 50 μg/ml streptomycin and
0.25 μg/ml amphotericin B. The first fraction was dis-
carded. The cell viability of the remaining fractions was
determined by trypan blue exclusion and the fractions
with viabilities not less than 80% were pooled. Cells were
plated at the density of 2 × 106 cells per 25 cm2 polysty-
rene flask in 10 ml of medium and cultured in a humidi-
fied atmosphere containing 5% CO2 – 95% air at 37C. The
medium was changed every 2 to 3 days. The experiments
were performed two weeks after plating when cells were
sub-confluent to confluent. The cells were treated with 50
nM TCDD or DMSO (control), and further incubated for
48 hrs. Total RNA from these cells was isolated and used
for DNA microarray and quantitative Real-Time PCR anal-
yses.
DNA microarray
The microarray method was carried out according to the
manufacture's instruction. Briefly, total RNA was extracted
from the TCDD-treated cells and control AEC using an
RNA extraction solution (Trizol). After Oligo-dT latex
beads treatment, double stranded cDNA libraries were
constructed from the mRNA of TCDD-treated cells and
the control AEC using an oligo-dT primer with a T7-pro-
moter sequence at the 5'-end. Biotin-labeled complemen-
tary RNA was in vitro transcribed by T7 promoter using
the cDNA libraries as template. The biotin-labeled RNA
was fragmented. Each sample was hybridized to a separate
oligonucleotide array (Affymetrix Human Genome
U133A) for 16 hours at 45C, and then washed and stained
with streptavidin phycoerythrin conjugate using Gene-
Chip Fluidics. The arrays were scanned by a Gene-Array
scanner using Affymetrix GeneChip Microarray Suite
(MAS) 5.0 software for scanning and basic analysis.
The Human Genome U133A array contains 22,277 probe
sets including 61 control probe sets, and analyzes the
expression level of 18,720 full length transcripts with
13,900 characterized human genes. The arrays incorpo-
rate a perfect match (PM)/mismatch (MM) probe pair
strategy. One probe from the pair perfectly matches its tar-
get sequence while the other contains a mismatch located
at the center of the 25-mer sequence. This probe pairing
design helps identify and subtract non-specific hybridiza-
tion and background signal. For each probe pair, the MM
signal was subtracted from the PM signal. The average of
these differences was reflective of the level of expression of
the gene. The global method of scaling/normalization was
performed by MAS 5.0 software. A program (Pathway-
Finder) was used for pathway analysis. Three independent
experiments were performed.
Quantitative real-time PCR
Messenger RNA was extracted using an RNA extraction
solution (Trizol) and oligo-dT latex beads as described
previously [15,16]. Five micrograms of mRNA prepara-Page 2 of 9
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ble stranded cDNA molecules. Complementary DNA was
quantified by UV absorption measurement, and 1 ng was
subjected to the PCR reaction as template. As an internal
standard, TATA binding protein (TBP) was used instead of
GAPDH, since GAPDH gene expression was affected by
the TCDD treatment (data not shown). Quantitative real-
time PCR was carried out in an ABI PRISM® 7000
Sequence Detection System (Applied Biosystems; Foster
City, CA), according to the manufacture's instructions.
PCR reaction involved template cDNA samples, Advan-
tage Taq Plus DNA polymerase (Clontech Laboratories,
Inc.; Mountain View, CA), dNTP, and Syber Green. The
thermal cycling conditions included an initial incubation
of samples at 94°C for 2 min, followed by appropriate
cycles of 94°C for 20 sec, 54°C for 30 sec and 72°C for 45
sec. Syber Green fluorescence was used to detect the
amplified products. Serial dilutions of the templates were
used to create a concentration curve, and relative expres-
sion levels were calculated using TBP as normalization
control for each sample. Abundance of each gene was
referred to as a Ct value in this system [16,17]. Three inde-
pendent experiments using AEC from three women were
performed. Comparisons between the genes were per-
formed using one-way ANOVA. The significance of the
differences between the mean values of
cytochromeP4501A1 (CYP1A1) and each gene was tested
using paired t-test. P < 0.05 was considered statistically
significant.
Results
Among the 22,277 genes spotted on the array, 12,509
genes were expressed in AEC population. Six hundred and
ninety six TCDD-sensitive candidate genes were picked
up; 326 were TCDD-inducible and 370 were TCDD-sup-
pressive candidate genes (cut-off values of 1.9 as inducible
and 0.5 as suppressive genes). Specific primers for 55
genes among 696 TCDD-sensitive candidate genes were
synthesized (Table 1). Those genes were selected for two
reasons. One reason was that TCDD-sensitive genes in rat
placenta had been examined previously [16]. In order to
reveal the relationship of sensitive genes between rat pla-
centa and AEC, those genes were selected. Another reason
was that even the candidate genes might not represent
actual sensitive genes, because false positive signals could
not be excluded from the array data, especially when
induction or suppression ratios were near 1.9 or 0.5.
Therefore we selected genes with higher ratios for real-
time PCR.
Genes that showed expression ratios (TCDD-treated/con-
trol) of more than 1.9 or less than 0.6 were finally identi-
fied as TCDD-sensitive. Among 55 genes analyzed, 38
genes were TCDD-inducible (Table 2), 4 were -suppres-
sive (Table 3), and 13 were neither of them, by both DNA
microarray technology and quantitative real-time PCR.
TCDD-inducible genes were categorized into several
groups. Enzyme genes include CYP1A1 and
cytochromeP4501B1 (CYP1B1) which are known as the
typical TCDD target genes. One of the remarkable find-
ings of the present experiment was that many interferon-
related genes were induced in TCDD-treated human AEC
(Figure 1). The expression of interferon-inducible genes,
that is, interferon induced transmembrane protein 1
(IFITM1), interferon, alpha-inducible protein (G1P2),
interferon, alpha-inducible protein 27 (IFI27) and inter-
feron-induced protein with tetratricopeptide repeats 1
(IFIT1) was strongly enhanced. The genes involved in the
interferon gene expression and signaling pathway, that is,
interferon regulatory factor 7 (IFR7), interferon-stimu-
lated transcription factor 3, gamma 48 kDa (ISGF3G) and
signal transducer and activator of transcription 1 (STAT1),
were also up-regulated.
The other aspect in TCDD-treated human AEC was that
integrin, alpha 10 (ITGA10), integrin, alpha 2 (ITGA2),
and matrix metalloproteinase 9 (MMP9), which were
genes involved in collagen synthesis and degradation,
were also induced by TCDD treatment. However no
changes in cellular morphology, number and viability
were observed under the experimental conditions.
Discussion
The amniotic membrane composes the innermost layer,
nearest the fetus, of the fetal membranes containing the
fetus and amniotic fluid [14]. It contains no blood vessels
or nerves; the nutrients it requires are supplied by the
amniotic fluid. The amniotic epithelium derived from epi-
blasts of embryo, laid in the most interior of the amniotic
membrane, is in contact with amniotic fluid directly. The
DNA microarray is a powerful and comprehensive
method to identify inducible or suppressive genes by a
given hormonal or pharmacological treatment. Using
DNA microarray and quantitative real-time PCR technol-
ogy, we analyzed TCDD-inducible genes in primary cul-
tures of human AEC.
We measured gene expression after 48 hour incubation.
Therefore early induced genes are not included in the
present study. Biological persistence of TCDD is well
known. It is reported that the expression of CYP1A1
mRNA was shown after 6 hours and sustained for up to 72
hours in human colon carcinoma cells treated with TCDD
[18]. The maximum effect of TCDD on the expression of
FSH receptor mRNA in rat granulosa cell cultures was
shown after a 48 hour-incubation in our previous study
[19]. The effect of TCDD on the expression of LH receptor
mRNA was shown after 24 hours and sustained for up to
72 hours in the same cells [20]. Therefore, we studiedPage 3 of 9
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Arylsulfatase B ARSB Forward Primer GTGGTGTGATCTCGGCTCACT
Reverse Primer CGTGGTGGTGTATGCCTGTAAT
Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 CHST6 Forward Primer GAAACTGAGTCCACCACTTGAGAA
Reverse Primer TTATTGCTCCTAAAGTCTTCGACTTG
Cytochrome P450 1A1 CYP1A1 Forward Primer AGCGGAAGTGTATCGGTGAGA
Reverse Primer CTGAATTCCACCCGTTGCA
Cytochrome P450 1B1 CYP1B1 Forward Primer AGCAGGCTTGCCCAGTACATT
Reverse Primer AAATAGGCTACAGCAGCCCAAA
Dehydrogenase/reductase (SDR family) member 2 DHRS2 Forward Primer TACTCATGCTAGGCTTGAGGAAGA
Reverse Primer CACCAAGAACCCCACATGTTAA
Fucosyltransferase 2 (secretor status included) FUT2 Forward Primer CCAGTGTGCATACAGTCATGGA
Reverse Primer CACGGTGCACTATATTCCCTAACTC
GDP-mannose 4,6-dehydratase GMDS Forward Primer GCCAAGGACTATGTGGAGGCTAT
Reverse Primer ACAAATTCCCGGACACTATGGA
Matrix metalloproteinase 9 MMP9 Forward Primer TTCCAGTACCGAGAGAAAGCCTAT
Reverse Primer GGTCACGTAGCCCACTTGGT
Membrane metallo-endopeptidase MME Forward Primer ATTCCTTTGGGCCTCTGCTT
Reverse Primer TGGGAAGGCAGCATTGGA
Mitochondrial thioredoxin reductase TXNRD2 Forward Primer CTGAGGAAACTCTTATCAGAACATTACAC
Reverse Primer GCGACGCGGTGCTACAA
Podocalyxin-like PODXL Forward Primer GCAGAGAGGGCAAGAGTAAAACTG
Reverse Primer GAGTCATCTGTGTCCTCCATGCT
Poly (ADP-ribose) polymerase family, member 12 ZC3HDC1 Forward Primer TTCTCAGAGTCTCATGGCATCATAGT
Reverse Primer GTCAGAACAACAGGCAGAAGTGA
Stearoyl-CoA desaturase SCD Forward Primer AGGAATGTCCACCATGAACTTGATA
Reverse Primer CACCGCTTCTCCAATGGATT
Ubiquitin-conjugating enzyme E2E 1 (UBC4/5 homolog, yeast) UBE2E1 Forward Primer GGTGGGAAGTATTGCCACTCA
Reverse Primer GTGAAACCCCAATTTATGTAGCGTAT
Uridine phosphorylase 1 UPP1 Forward Primer CGATTAAGAGACAGAGAATCTTGGATTA
Reverse Primer GAAACCCCAAATCAGGCTAACA
Interleukin 12B IL12B Forward Primer GACAAGTAGTTATGGCTAAGGACATGA
Reverse Primer AGGGATTCCAGATTTTCTTTGCA
Distal-less homeo box 2 DLX2 Forward Primer AGCCTGGACTTGGACACAGAGT
Reverse Primer GGGTTGCTGAGGTCACTGCTA
Early growth response 1 EGR1 Forward Primer AAGCCAAGCAAACCAATGGT
Reverse Primer ACTCTGACACATGCTCTGAGAATACTG
High mobility group AT-hook 1 HMGA1 Forward Primer GTCCCCTACTCCCTCTTCACTGT
Reverse Primer ACCTGGACAATAAGTGACTGCATCT
Interferon regulatory factor 7 IFR7 Forward Primer GCCTGGTCCTGGTGAAGCT
Reverse Primer GAAGCACTCGATGTCGTCATAGA
Interferon-stimulated transcription factor 3, gamma 48 kDa ISGF3G Forward Primer AAGTAGACTCATTCTTCACACGATTGAC
Reverse Primer AGCCAGTGTGTGCGAGGATT
Myeloid/lymphoid or mixed-lineage leukemia (trithorax 
homolog, Drosophila); translocated to, 10 (MLLT10)
MLLT10 Forward Primer GACCATTAAAAGCTCACCACTAGAGTTC
Reverse Primer CTGCGGTACTGTCACATCAAAAG
N-myc (and STAT) interactor (NMI) NMI Forward Primer CGTGAAGATCAAATGAGAGACAAACT
Reverse Primer CTCCCGGACTGTCTGTCATAGTC
Nuclear antigen Sp100 SP100 Forward Primer CAGCTGTTTTGTTGACATTCTGAA
Reverse Primer TGGAAGAAGACTGACCTGGTACCT
Tumor necrosis factor, alpha-induced protein 3 TNFAIP3 Forward Primer GAGTAAATTGGCCTCTTTGATACACTT
Reverse Primer AGGAGAAGCACGAAACATCGAT
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F 
(avian)
MAFF Forward Primer CCAGAAGGCAGAGGTTGTAGTGA
Reverse Primer AGGAGCCGGGCAATATTTTTTA
GABA-B receptor GPR51 Forward Primer TGTGCGTCTGTAACCCTTTGTG
Reverse Primer AATGGGTGAACCTACAGTATCAGTAAGA
Interferon, alpha 1 IFNA1 Forward Primer TGATGAATGCGGACTCCATCT
Reverse Primer GACAACCTCCCAGGCACAAG
Signal transducer and activator of transcription 1 STAT1 Forward Primer TTGAGTGGATGATGTTTCGTGAAPage 4 of 9
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Solute carrier family 2 (facilitated glucose transporter), 
member 1
SLC2A1 Forward Primer ACCACTGCAACGGCTTAGACTT
Reverse Primer TGGGTAACAGGGATCAAACAGAT
Solute carrier family 2 (facilitated glucose transporter), 
member 3
SLC2A3 Forward Primer TTGCTCTGGGTGGAAGTACGTT
Reverse Primer ACCAAGAAGGGAAAGGGAGACT
Amphiregulin AREG Forward Primer GCTGCCTTTATGTCTGCTGTGA
Reverse Primer CGTTCCTCAGCTTCTCCTTCA
Caveolin 2 CAV2 Forward Primer CTCATATCCTTTTGAAGGTAGTTGCA
Reverse Primer GGTGATGCTTTAAGGTAATGATTATGC
DnaJ (Hsp40) homolog, subfamily C, member 3 DNALC3 Forward Primer AAGAAGTTTGACGACGGAGAAGA
Reverse Primer TTGAACCCTTGCCATGAGTTC
Epiregulin EREG Forward Primer CAATGTAACTCCACTGTTCTCCTGAA
Reverse Primer CTGGTGGTGATTGAATTTAGTCTCA
Epithelial membrane protein 1 EMP1 Forward Primer AACTCTTGTGGTACCTAGTCAGATGGTA
Reverse Primer GCAAAGCAATGCCTGCTTAAC
FLJ20035 FLJ20035 Forward Primer TAGTCCAGGATAACAGGATGAATGAA
Reverse Primer ACATAGCTCACGCAAGGAAACA
Insulin induced gene 1 INSIG1 Forward Primer AAGCTTAGAGGAACTTGCCTGTGA
Reverse Primer TACTCCAAGACATTTCCCTCAAAAC
Integrin, alpha 10 ITGA10 Forward Primer AGTAAAGGCAGTTGGATTCTCATAGAC
Reverse Primer GAGCTGCACTCTGGAGACCAAT
Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) ITGA2 Forward Primer AGATGATTTGGTCAGATTGGGATAAG
Reverse Primer TGGGTGGTGTTTCTCAAAGTGT
Interferon induced transmembrane protein 1 IFITM1 Forward Primer TCCCTGTTCAACACCCTCTTCT
Reverse Primer GTCACGTCGCCAACCATCTT
Interferon, alpha-inducible protein G1P2 Forward Primer CCTGCTGGTGGTGGACAAAT
Reverse Primer CCGCTCACTTGCTGCTTCA
Interferon, alpha-inducible protein 27 IFI27 Forward Primer TGGCCAGGATTGCTACAGTTG
Reverse Primer TATGGAGGACGAGGCGATTC
Interferon-induced protein with tetratricopeptide repeats 1 IFIT1 Forward Primer GAAACTTCGGAGAAAGGCATTAGA
Reverse Primer GCTCATAGTACTCCAGGGCTTCAT
Interferon-induced protein with tetratricopeptide repeats 2 IFIT2 Forward Primer CTTGGAACGATTGAGATTTTCTAGGT
Reverse Primer CCCAGAGTGTGGCTGATGCT
Keratin 6A KRT6A Forward Primer TTCAGAACAACTTCCACTTACTTTCC
Reverse Primer GTCACTTGTGCTTTCATGGATACTG
Low density lipoprotein receptor-related protein 3 LRP3 Forward Primer CCCATCCTATGGTCAGCTCATC
Reverse Primer CGTGCCGACGCATCTGT
Presenilin 2 (Alzheimer disease 4) PSEN2 Forward Primer CACAGCAGGTTTATCCAGATGAAC
Reverse Primer CACTCCCGAGCACACTCTTTG
Ras-related associated with diabetes RRAD Forward Primer TTGAGACATCAGCGGCATTG
Reverse Primer CGTCGTGCGTTGGCTTCT
Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), 
member 2
SERPINB2 Forward Primer GTGAATGAGGAGGGCACTGAAG
Reverse Primer AGAAAAGGATGATCTGCCACAAAC
Small proline-rich protein 3 SPRR3 Forward Primer CCATGTCCTTCAACGGTCACT
Reverse Primer AGCATCTGGTGGTTGGCTTCT
Tripartite motif-containing 14 TRIM14 Forward Primer GCAGAGACAGAGCTAGACTGTAAAGGT
Reverse Primer CCTGGTCACACAATTGATATGGA
Tumor necrosis factor TNF Forward Primer GAATGTGTGGCCTGCACAGT
Reverse Primer CCAGATGTCAGGGATCAAAGC
Chromosome 10 open reading frame 116 C10orf116 Forward Primer ACAGCCTGGCCCTGATCTC
Reverse Primer GCTTGCGAGGAATCATGAAGT
Pleckstrin homology-like domain, family A, member 1 PHLDA1 Forward Primer ACGAGCACATTTCTATTGTCTTCACT
Reverse Primer TCGCAAGTTTTCAGTAGGGTGAT
Table 1: Primers used for quantitative real-time PCR (Continued)Page 5 of 9
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incubation.
The most striking observation in this experiment was that
many interferon-inducible genes were prominently up-
regulated in TCDD-treated human AEC; the increase of
gene expression of IFITM1, G1P2, IFI27 and IFIT1 was
equal to or far more than that of CYP1A1 and CYP1B1
which are well known as TCDD-inducible genes. The
genes involved in the interferon gene expression and sig-
naling pathway, that is, IFR7, ISGF3G and STAT1, were
also up-regulated. The induction of interferon-related
genes by TCDD was first reported by Mizutani et al., in the
placentas of TCDD-treated Holtzman rats [16]. The
present study confirmed that TCDD induces interferon-
related genes in cells derived from human fetuses.
On the other hand, the up-regulation of glucose trans-
porter genes was not observed in AEC culture by DNA
microarray analysis (data are not shown), though they
were strongly up-regulated in TCDD-treated rat placentas
[16]. The placenta is the organ rich in blood vessels and it
is reported that exposure to TCDD causes a hypoxic state
in the placentas and the glucose kinetics are also altered in
those organs [21,22]. On the other hand, interferon is
known to be involved in the regulation of angiogenesis.
Table 2: TCDD-inducible genes in human AEC





Enzyme Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 2.46 1.92 33.82 NM_021615
Cytochrome P450 1A1 6.79 10.36 20.74 NM_000499
Cytochrome P450 1B1 3.99 7.13 19.36 NM_000104
Dehydrogenase/reductase (SDR family) member 2 2.57 3.17 26.62 NM_182908
Fucosyltransferase 2 (secretor status included) 2.85 1.99 27.64 NM_000511
Matrix metalloproteinase 9 4.49 4.67 23.58 NM_004994
Membrane metallo-endopeptidase 2.75 2.88 27.60 NM_007287
Podocalyxin-like 3.50 3.83 22.26 NM_005397
Poly (ADP-ribose) polymerase family, member 12 4.02 4.57 26.69 NM_022750
Stearoyl-CoA desaturase 2.56 2.06 27.95 AB032261
Uridine phosphorylase 1 2.56 2.40 31.76 NM_003364
Transcription Factor Distal-less homeo box 2 3.05 2.50 24.50 NM_004405
Interferon regulatory factor 7 2.82 4.46 25.21 NM_004030
Interferon-stimulated transcription factor 3, gamma 48 kDa 1.54 3.78 25.44 NM_006084
N-myc (and STAT) interactor (NMI) 2.61 3.30 26.18 NM_004688
Nuclear antigen Sp100 1.06 2.28 29.04 NM_003113
Tumor necrosis factor, alpha-induced protein 3 2.50 2.18 25.94 NM_006290
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) 3.33 3.75 27.11 NM_012323
Signal Transducer GABA-B receptor 2.59 2.56 29.53 AF056085
Signal transducer and activator of transcription 1 2.84 2.85 21.55 NM_007315
Structural Protein and 
Other Groups
Amphiregulin 2.80 10.70 22.56 NM_001657
Epiregulin 4.18 3.19 27.35 NM_001432
Epithelial membrane protein 1 3.01 2.84 25.54 NM_001423
FLJ20035 11.16 5.58 30.53 NM_017631
Insulin induced gene 1 2.53 2.61 26.85 NM_005542
Integrin, alpha 10 2.72 1.91 25.04 AF112345
Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 2.42 3.54 25.17 NM_002203
Interferon induced transmembrane protein 1 5.31 31.85 27.24 NM_003641
Interferon, alpha-inducible protein 12.65 18.72 21.80 NM_005101
Interferon, alpha-inducible protein 27 12.13 16.84 23.13 NM_005532




Keratin 6A 3.23 4.45 21.99 NM_005554
Ras-related associated with diabetes 2.72 2.42 23.57 NM_004165
Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 11.00 12.36 24.86 NM_002575
Small proline-rich protein 3 2.97 3.56 22.33 NM_005416
Tripartite motif-containing 14 4.61 2.56 27.43 NM_014788
Tumor necrosis factor 3.89 3.04 26.79 NM_000594
Function Unknown Pleckstrin homology-like domain, family A, member 1 2.81 5.13 27.91 NM_007350Page 6 of 9
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feron signaling pathway impaired the angiogenesis in
TCDD-treated rat placentas and brought about a hypoxic
state in the placentas which up-regulated glucose trans-
porter gene expression [16]. It was deduced that the
expression of glucose transporter genes was not up-regu-
lated in AEC, since both the control and TCDD-treated
cells had an adequate supply of oxygen when in the in
vitro culture condition. AEC cultures in the present study
were performed under air conditions. In future studies,
comparing TCDD-inducible genes between AEC cultures
under hypoxic conditions and under air conditions would
verify the inference and show which condition is closer to
in vivo.
Table 3: TCDD-suppressive genes in human AEC
Molecular function Gene Name Array ratio Real Time PCR ratio Ct Accession
Signal Transducer Interferon, alpha 1 5.03 0.22 34.80 NM_024013
Transporter Solute carrier family 2 (facilitated glucose transporter), member 3 0.54 0.38 23.13 NM_006931
Structural Protein Low density lipoprotein receptor-related protein 3 2.69 0.56 26.61 NM_002333
Function Unknown Chromosome 10 open reading frame 116 2.74 0.28 33.78 NM_006829
Induction of CYP1A1, CYP1B1 and interferon related genes in human AEC by TCDDFig re 1
Induction of CYP1A1, CYP1B1 and interferon related genes in human AEC by TCDD. Expression levels were determined by 
DNA microarray and quantitative real-time PCR analyses as described in Methods. Values were expressed as fold induction 
(TCDD/control). The representative microarray data are shown as yellow columns. The values obtained by PCR analyses are 
shown as red columns. The data are shown as mean ± SD of three independent experiments. *, P < 0.05 compared with the 
value of CYP1A1.Page 7 of 9
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and viability were observed under the experimental con-
ditions, it was an interesting observation that the expres-
sion of genes related to the synthesis and degradation of
collagen, that is, MMP9, ITGA2 and ITGA10 were also up-
regulated by TCDD in human AEC. Martinez JM et al
reported the induction of MMP1, MMM9 and tissue
inhibitor of metalloproteinase 3 in TCDD-treated human
airway epithelial cells using microarray analysis in 2002
[23]. Thereafter, increased mRNA levels of MMPs were
reported in TCDD-treated human cells, such as, MMP1 in
keratinocytes [24] and melanoma cells [25], MMP2 in
melanoma cells [25], MMP3 and MMP7 in endometrial
cells [26], and MMP9 in prostate cancer cells [27] and
melanoma cells [25]. Although the mechanisms of induc-
tion of MMP genes by TCDD are not fully clarified, Mur-
phy et al reported that TCDD activation of MMP1 mRNA
expression was mediated through increased promoter
activity [24]. Villano CM et al reported aryl hydrocarbon
receptor dependent MMP1, 2, and 9 expression by TCDD
and speculated that MMP expression may be a common
endpoint for activation of the aryl hydrocarbon receptor
pathway [25]. It is speculated that TCDD caused patho-
logical lesions by altering the expression of genes involved
in matrix remodeling [24]. On the other hand, increased
premature labor is reported in women exposed to dioxins
in Chapaevsk [28]. The tensile strength of fetal mem-
branes is provided almost exclusively by the amnion, and
the interstitial collagens are believed to be the major
source of the tensile strength of this tissue. AEC secrete not
only collagens and noncollagenous glycoproteins but also
MMPs [14]. Considering these biological characters of the
amnion and the present observations on increased expres-
sion of genes related to the synthesis and degradation of
collagens, our findings permit a better understanding of
the pathology of premature labor by dioxins. The study of
mechanisms on the induction of these genes by TCDD in
human AEC would be the subject of future work.
The data of TCDD-inducible and -suppressive genes in
human AEC culture is available at ED-Genes [29].
Conclusion
We identified 38 TCDD-inducible genes in human AEC
using DNA microarray and quantitative real-time PCR
analyses. Interferon-inducible genes and genes related to
collagen synthesis or degradation were up-regulated.
These observations indicate that the comprehensive meth-
ods used in this study are useful in investigating the effects
of dioxins on human feto-placenta.
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